ABVC vs. ELAB, AKTX, ERNA, AVTX, MIRA, MBRX, MTEM, KPRX, GHSI, and MNPR
Should you be buying ABVC BioPharma stock or one of its competitors? The main competitors of ABVC BioPharma include Elevai Labs (ELAB), Akari Therapeutics (AKTX), Eterna Therapeutics (ERNA), Avalo Therapeutics (AVTX), MIRA Pharmaceuticals (MIRA), Moleculin Biotech (MBRX), Molecular Templates (MTEM), Kiora Pharmaceuticals (KPRX), Guardion Health Sciences (GHSI), and Monopar Therapeutics (MNPR). These companies are all part of the "pharmaceutical preparations" industry.
Elevai Labs (NASDAQ:ELAB) and ABVC BioPharma (NASDAQ:ABVC) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, community ranking, analyst recommendations, media sentiment, profitability, risk and earnings.
Elevai Labs and ABVC BioPharma both received 0 outperform votes by MarketBeat users.
Elevai Labs has higher revenue and earnings than ABVC BioPharma.
In the previous week, Elevai Labs and Elevai Labs both had 4 articles in the media. ABVC BioPharma's average media sentiment score of 0.44 beat Elevai Labs' score of 0.40 indicating that Elevai Labs is being referred to more favorably in the media.
22.2% of Elevai Labs shares are held by institutional investors. Comparatively, 11.4% of ABVC BioPharma shares are held by institutional investors. 11.9% of ABVC BioPharma shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.
Elevai Labs has a net margin of 0.00% compared to Elevai Labs' net margin of -6,919.08%. ABVC BioPharma's return on equity of 0.00% beat Elevai Labs' return on equity.
Summary
Elevai Labs beats ABVC BioPharma on 7 of the 9 factors compared between the two stocks.
Get ABVC BioPharma News Delivered to You Automatically
Sign up to receive the latest news and ratings for ABVC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ABVC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
ABVC BioPharma Competitors List
Related Companies and Tools
